Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Metz Gercek, Sigrid ^a   Maieron, Andreas ^a   Strauß, Reinhild ^b   Wieninger, Peter ^c   Apfalter, Petra ^a   Mittermayer, Helmut ^a  

^a ELISABETHINEN HOSPITAL   (Austria)

^b Austrian Federal Ministry of Health   (Austria)

^c Main Association of Austrian Social Security Institutions   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFPODOXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; MINOCYCLINE; NORFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRIA; BACTERIUM ISOLATE; CEREBROSPINAL FLUID; DRUG USE; DRUG UTILIZATION; ESCHERICHIA COLI; HEALTH CARE PRACTICE; HUMAN; PENICILLIN RESISTANCE; TREATMENT INDICATION; TREND STUDY; CLINICAL PRACTICE; PRESCRIPTION; STATISTICS;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; AUSTRIA; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS;

EID: 66749164674     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-61     Document Type: Article

References (20)

1. Lautenbach E Polk RE Resistant gram-negative bacilli: A neglected healthcare crisis? Am J Health Syst Pharm 2007, 64(23 Suppl 14):S3-21 10.2146/ajhp070477 18029939
2. Hutchinson JM Patrick DM Marra F Ng H Bowie WR Heule L Muscat M Monnet DL Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada Can J Infect Dis 2004, 15(1):29-35 2094921 18159441
3. Kennedy KJ Roberts JL Collignon PJ Escherichia coli bacteraemia in Canberra: Incidence and clinical features Med J Aust 2008, 188(4):209-213 18279126
4. Bronzwaer SL Goettsch W Olsson-Liljequist B Wale MC Vatopoulos AC Sprenger MJ European Antimicrobial Resistance Surveillance System (EARSS): Objectives and organisation Euro Surveill 1999, 4(4):41-44 12631906
5. Goettsch W Bronzwaer SL de Neeling AJ Wale MC Aubry-Damon H Olsson-Liljequist B Sprenger MJ Degener JE Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS) Clin Microbiol Infect 2000, 6(2):59-63 10.1046/j.1469-0691.2000.00027.x 11168073
6. CLSI Performance Standards for Antimicrobial Susceptibility Testing Approved standard M100-S17, 27-1: Wayne, PA
7. Goossens H Ferech M Coenen S Stephens P Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries Clin Infect Dis 2007, 44(8):1091-1095 10.1086/512810 17366456
8. Ferech M Coenen S Dvorakova K Hendrickx E Suetens C Goossens H European Surveillance of Antimicrobial Consumption (ESAC): Outpatient penicillin use in Europe J Antimicrob Chemother 2006, 58(2):408-412 10.1093/jac/ dkl186 16735415
9. Ferech M Coenen S Malhotra-Kumar S Dvorakova K Hendrickx E Suetens C Goossens H European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe J Antimicrob Chemother 2006, 58(2):401-407 10.1093/jac/dkl188 16735414
10. Coenen S Ferech M Dvorakova K Hendrickx E Suetens C Goossens H European Surveillance of Antimicrobial Consumption (ESAC): Outpatient cephalosporin use in Europe J Antimicrob Chemother 2006, 58(2):413-417 10.1093/jac/dkl185 16735416
11. Ferech M Coenen S Malhotra-Kumar S Dvorakova K Hendrickx E Suetens C Goossens H European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe J Antimicrob Chemother 2006, 58(2):423-427 10.1093/jac/dkl183 16735418
12. Ryan RJ Lindsell C Sheehan P Fluoroquinolone resistance during 2000-2005: An observational study BMC Infect Dis 2008, 8:71 2424048 18501015 10.1186/1471-2334-8-71
13. Goossens H Ferech M Stichele Vander R Elseviers M Outpatient antibiotic use in Europe and association with resistance: A cross-national database study Lancet 2005, 365(9459):579-587 15708101
14. Ena J Arjona F Martinez-Peinado C Lopez-Perezagua Mdel M Amador C Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli Urology 2006, 68(6):1169-1174 10.1016/j.urology.2006.08.1075 17169640
15. Lautenbach E Patel JB Bilker WB Edelstein PH Fishman NO Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes Clin Infect Dis 2001, 32(8):1162-1171 10.1086/ 319757 11283805
16. Rodriguez-Bano J Navarro MD Extended-spectrum beta-lactamases in ambulatory care: A clinical perspective Clin Microbiol Infect 2008, 14(Suppl 1):104-110 10.1111/j.1469-0691.2007.01866.x 18154533
17. Talan DA Krishnadasan A Abrahamian FM Stamm WE Moran GJ Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis Clin Infect Dis 2008, 47(9):1150-1158 10.1086/592250 18808361
18. Gagliotti C Buttazzi R Sforza S Moro ML Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli J Infect 2008, 57(3):179-184 10.1016/j.jinf.2008.07.004 18707763
19. File TM Community-acquired pneumonia Lancet 2003, 362(9400):1991-2001 10.1016/S0140-6736(03)15021-0 14683661
20. García-Suárez M Villaverde R Caldevilla AF Méndez FJ Vázquez F Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumoncoccal isolates in Asturias, Spain Jpn J Infect dis 2006, 59(5):299-05 17060695